The pharmaceutical sector, a beacon of innovation, stands tall in Europe's economic landscape. Yet even a robust industry is not immune to financial challenges. With a market value exceeding $280 ...

Over the last few years, Supriya Life Sciences has expanded beyond its traditional API business. By targeting markets ...

The CDMO Sector Holds a Core Position in the Pharmaceutical Industry As a major part of the outsourcing pharmaceutical service industry, CDMOs support pharmaceutical companies across the entire chain, ...

Despite the stigma, the coca plant is effectively entering the drug reform movement as part of an expected “third wave of decriminalization” along with other controlled substances including ...

The growing presence of private equity in the pharmaceutical industry—from contract research to manufacturing—has the potential to reshape how drugs are developed, produced, regulated, and accessed.

In part two of this trends article, we will continue with the last five trends shaping the pharmaceutical supply chain and manufacturing industry in 2023. Drug modalities represent different types of ...

The chemical manufacturer has entered into a definitive agreement to acquire a 43.3%-48.2% equity stake in Bliss GVS Pharma, along with an open offer to the public shareholders of the company. Shares ...